GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BCAL Diagnostics BDX.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.07

+1.49%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

BCAL Diagnostics — daily ASX:BDX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View BCAL Diagnostics on TradingView ↗
Market value
A$24.5m
Last close × shares
Volume
11.4k
Shares, 9 Nov 2026

About BCAL Diagnostics

Its shares trade on ASX under the ticker BDX.AX. It has been listed since 21 July 2021. In the fiscal year to 30 June 2025, it reported revenue of A$2.8m and a net loss of A$7.2m. At that date it held total assets of A$9.9m and shareholders' equity of A$6.2m.

BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-07-21. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. The company developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The firm has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.

Figures and description from our data supplier, not checked against the company's own report.

More about BCAL Diagnostics →

Latest on BCAL Diagnostics

Our reporting

We have not reported on BCAL Diagnostics yet.

Next results

23 Feb 2027

Due on 23 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is BCAL Diagnostics's ticker?

BCAL Diagnostics trades as BDX.AX on ASX, under ISIN AU0000160921.

What was BCAL Diagnostics's last closing price?

0.07 on 9 Nov 2026. The figure is in AUD and is never converted.

When does BCAL Diagnostics next report results?

Results are expected on 23 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.